Will personalised medicine become the norm of cancer treatment? In this Science Surgery instalment, we asked experts for their thoughts on this question.
Physicists in Cambridge are using light and sound to gather information on prostate cancer in mice. This could show doctors how aggressive a tumour is.
New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
We’re backing a new project that could boost our understanding of pancreatic cancer and increase opportunities for patients to join clinical trials.
Advances in MRI technology could help scientists and doctors tailor cancer treatment by measuring the oxygen levels inside tumours.
This year’s British Science Week runs from 10th – 19th March, and the theme is ‘change’.
Here are our highlights from day 3 of the NCRI Cancer Conference, including personalised treatment for prostate cancer, and new surgery tech.
On Ada Lovelace Day 2016, we speak to Dr Bissan Al-Lazikani about how she is using computers to help personalise cancer treatment.
Last month’s 2016 MAP conference showcased progress so far on personalised cancer treatment, and discussed future challenges.